BVP 2026 EIIS Fund - Register your Interest Now - Up to 50% Tax Relief on Investments - Applications Open October 2026

Telenostic are committed to developing next-generation devices that lead the way for the future of the industry.

OvaCyte is Telenostics inaugural parasitology diagnostic technology. A breakthough parasite egg recovery and identification platform. OvaCyte introduces a novel intestinal parasite analysis technology at the point of care, bringing efficiency, convenience, and cost effective diagnostics to the veterinarian.

This is an EIIS Fund Investment